Prominent IP Updates on Jan 02, 2015

Indian Patent Office revokes the patent of Roche’s osteoporosis drug Bonviva

The Patent Office has revoked the patent of Swiss drug major F Hoffmann-La Roche AG for its osteoporosis drug ibandronate sodium – sold under the brand Boniva in the US and Bonviva in Asia – on a post-grant opposition filed by Cipla.

United States grants Heptares multiple patents

MRC spin-out Heptares Therapeutics, a drug discovery and development company, has been granted multiple key patents in the US relating to its GPCR-focused platform.

Apple Faces New Class Action over False iDevice Storage Capacities

Floridians by the name of Paul Orshan and Christopher Endara have filed a class action lawsuit against Apple for storage capacity misrepresentations and omissions relating to Apple’s iOS 8. According to the filing, “iOS 8 uses an unexpectedly large percentage of the storage capacity on 8 GB and 16 GB iPhones, iPads and iPods.” While this is an annoyance lawsuit, it’s an industry practice that should end – and Apple should lead the way.

IBM Assigned Patent for Integrated Circuits Including finfet Devices with Lower Contact Resistance and Reduced Parasitic Capacitance

International Business Machines Assigned Patent for Integrated Circuits Including FINFET Devices with Lower Contact Resistance and Reduced Parasitic Capacitance By Targeted News Service ALEXANDRIA, Va., Jan. 1 — International Business Machines, Armonk, New York, and GlobalFoundries, Grand Cayman, Cayman Islands, have been assigned a patent (8,921,191) developed by four co-inventors for the “integrated circuits including FINFET devices with lower contact resistance and reduced parasitic capacitance and methods for fabricating the same –

iQ Power : awarded further patents in Japan and USA

iQ Power AG, a developer and marketer of technologies for environmentally friendly and technologically innovative starter batteries for motor vehicles and licenses in these technologies,announces the granting of patents for the iQ Power first generation technology.

Brief-idex acquires pivotal algorithm and patents for touch fingerprint sensors

Says consideration to purchase patents and algorithm software source code is structured as a royalty based transaction with a guaranteed minimum, of which $2 million will be paid in cash imminently

USPTO grants patent to Ton Duc Thang University for new invention

For the very first time, Ton Duc Thang University has received a patent granted by the United States Patent and Trademark Office for its convertible patient bed.

Nike Patents Golf Swing Monitoring and Recyclable Golf Balls

Nike, Inc. which is headquartered in Washington County near Beaverton, OR, is a major developer, manufacturer and marketer of footwear and other athletic apparel all over the world. Known for its high-end footwear touted by professional basketball players and other sports stars, Nike recently unveiled its latest limited-edition sneakers, the “Mamba Moment,” to commemorate Kobe Bryant’s recent move ahead of Michael Jordan on the NBA’s all-time scoring list.

Knight Therapeutics Inc. And Neuraxon Inc. Form Partnership

Knight Therapeutics Inc. a leading Canadian specialty pharmaceutical company, today announced that it has entered into a strategic partnership with NeurAxon Inc. for the commercialization of NeurAxon’s innovative products in various stages of development (“Pharmaceuticals”) in Canada, Israel, South Africa and Russia (“Territory”).

Patent: Changes in language requirements in Norway

From 1st January 2015 new language requirements apply for national patent applications and for the validation of European patents.

Abattis Maintains it is Still the Worldwide Exclusive Licensee to Certain VDL Technology

Abattis Bioceuticals Corp., a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, wishes to advise its shareholders that contrary to public assertions made by Vertical Designs Ltd. (“VDL”), Abattis does not consider the parties’ worldwide exclusive license agreement (“License”) terminated.